April 2021 - Today is World Health Day! We will continue to do our best to build a fairer, healthier world for patients with CML. During these extraordinary times and current challenges for global health related to COVID-19, our main focus is to support physicians treating patients with CML around the world and to gain and share knowledge about COVID-19 and CML.

The iCMLf is collecting details of CML patients diagnosed with COVID-19. To date we have collected a total number of 642 cases from 48 countries. The iCMLf CML and COVID-19 data was first presented at ASH 2020 and a full publication is expected soon.

We are also putting together a CML vaccination study across sites in 15 countries to assess patients' attitude to being vaccinated, the actual uptake of vaccine by patients, potential side effects/toxicities associated with the vaccines and evidence of immunity by serology. More information will be provided soon.

March 2021 - The iCMLf continues to support the global CML community during the pandemic by providing the latest information on COVID-19 and CML. With the increasing availability of COVID-19 vaccines, up to date and relevant information is imperative for physicians treating blood cancers and their patients. The next highlight in our series of iCMLf Conversations is coming up with an expert talk on COVID-19 vaccines and CML to be held Wednesday, April 7^th at 13.30 CET.

Don’t miss this opportunity to stay up to date with the latest developments on COVID-19 vaccines for people with CML.

iCMLf Conversation on CML:
Update on COVID-19 vaccines and CML

Date: Wednesday, April 7^th at 13.30 Central European Time (CET)

Mandelieu La Napoule - NEW DATES: October 7-10, 2021

Chairs: J. Cortes, T.P. Hughes, D.S. Krause

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Deadline for Abstracts: May 8, 2021
Click here to submit your abstract

Contact: camille.dufour@univ-paris-diderot.fr

February 2021 - Today we join many other organizations supporting rare diseases and patients all over the world to raise awareness for rare diseases and their impact on patients lives.

There are over 300 million people living with a rare disease worldwide. Access to appropriate monitoring and treatment is still especially challenging in low- and middle-income countries.

CML is a rare condition and we will continue to improve access to treatment and care for patients affected by CML all over the world through our programs for physicians from the emerging regions and through our online education.

February 2021 - The iCMLf is pleased to announce Professor Susan Branford, SA Pathology and Centre for Cancer Biology in Adelaide as the 2021 Rowley Prize winner. This annual prize awarded by the International CML Foundation recognises outstanding contributions to the understanding of the biology of CML. Sue is a leading international authority on molecular monitoring for CML and a major contributor to international collaborative initiatives to establish guidelines and recommendations for producing reliable molecular data.

February 2021 - We are delighted to announce that Professor Giuseppe Saglio, Professor of Haematology and Internal Medicine at the University of Turin (Italy) has been awarded the 2021 Goldman Prize. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding contributions to the management of patients with CML and Professor Saglio is universally regarded as one of the greatest experts in CML treatment.

Page 24 of 44

Copyright © 2023 All Rights Reserved. The iCMLf is registered as charity no. 1132984 in England and Wales
Registered Address: International CML Foundation - 20 Eversley Road - Bexhill-On-Sea, East Sussex, TN40 1HE - UK